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The ability to selectively target the harmful microbial membrane over that of the host cell is one of the most important characteristics of the
antimicrobial peptides (AMPs). This selectivity strongly depends on the chemical and structural properties of the lipids that make up the cell
membrane. A systematic study of the initial membrane selectivity of protegrin-1 (PG-1), a β-sheet AMP, was performed using Langmuir
monolayers. Constant pressure insertion assay was used to quantify the amount of PG-1 insertion and fluorescence microscopy was employed to
observe the effect of PG-1 on lipid ordering. Charge and packing properties of the monolayer were altered by using lipids with different head
groups, substituting saturated with unsaturated lipid tail group(s) and incorporating spacer molecules. PG-1 inserted most readily into anionic films
composed of phosphatidylglycerol (PG) and lipid A, consistent with its high selectivity for microbial membranes. It also discriminated between
zwitteranionic phospholipids, inserting more readily into phosphatidylcholine (PC) monolayers than those composed of phosphatidylethano-
lamine, potentially explaining why PG-1 is hemolytic for PC-rich human erythrocytes and not for the PE-rich erythrocytes of ruminants. Increased
packing density of the monolayer by increased surface pressure, increased tail group saturation or incorporation of dihydrocholesterol diminishes
the insertion of PG-1. Fluorescence microscopy shows that lipid packing is disordered upon PG-1 insertion. However, the presence of PG-1 can
still affect lipid morphology even with no observed PG-1 insertion. These results show the important role that lipid composition of the cell
membrane plays in the activity of AMPs.
© 2006 Elsevier B.V. All rights reserved.Keywords: Antimicrobial peptide; Protegrin-1; Langmuir monolayer; Fluorescence microscopy; Peptide–membrane interaction; Model cell membrane; Selectivity;
Disordering; Phospholipid; DPPC; DPPE; DPPG; POPC; POPE; POPG; Lipid A; Dihydrocholesterol; Ganglioside1. Introduction
Antimicrobial peptides (AMPs) are a class of peptides known
to protect the host by selectively targeting and disrupting the
membrane of harmful microorganisms. They are part of the
native immune system of a variety of organisms such as frog
(magainin), horseshoe crab (tachyplesin), cow (indolicidin) and
human (LL-37 and defensins) and target a wide range of
bacteria, fungi, viral infection as well as some tumors[1,2].
AMPs are typically 10–40 amino acids long, containing cationic
amino acid residues and adopting an amphiphilic structure⁎ Corresponding author.
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doi:10.1016/j.bbamem.2006.08.001when bound to the membrane (α-helical and/or β-sheet).
Using their strong membrane affinity, many linear AMPs are
known to selectively disrupt the integrity of the target
membrane by pore formation via close packed peptides
(barrel-stave model) [3–6] or by the assembly of a combination
of peptide and lipid molecules (carpet [7–9] and torroidal model
[10–12]). This membrane affinity of AMPs does not depend on
a specific protein receptor, in contrast to the major histocom-
patibility complex, as similar antimicrobial activities have been
observed even with the counter stereoisomers synthesized using
D-amino acids which are not found in nature [6,13–15]. Instead,
the overall chemical and structural properties of AMPs are
thought to play a more important role. The AMP bactericidal
effects can be mimicked by various non-amino-acid-based
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perties [16–19].
What then, are the properties of the target membrane that
makes it susceptible to the action of AMPs? Prokaryotic cells
and eukaryotic cells have distinct membrane lipid composition.
The outer leaflet of the mammalian cell membrane is comprised
mainly of phosphatidylcholine (PC), sphingomyelin, phospha-
tidylethanolamine (PE) and cholesterol, which are all charge-
neutral at physiological pH [20]. In contrast, bacterial
membranes include substantial amounts of negatively charged
phospholipids, such as phosphatidylglycerol (PG) and cardio-
lipin [21]. Furthermore, in Gram-negative bacteria, the outer
leaflet of the outer membrane bilayer is composed mostly of
lipopolysaccharide (LPS), a polyanionic molecule. Though the
potential across the membrane may also contribute, the surface
selectivity of cationic AMPs is highly affected by the difference
in membrane lipid composition [22,23].
The subtle differences in the lipid composition in various
mammalian cell membranes can also result in the differences in
their susceptibilities to AMPs. A porcine AMP, protegrin-1
(PG-1), does not lyse the RBCs of sheep, cow and its native host
(pig), but can lyse those of human, rabbit and mouse [24]. It
should be noted that the concentration required to cause
cytotoxicity in mammalian cells is still up to an order of
magnitude higher than the minimum inhibitory concentration
against bacteria, but the difference in activity towards various
mammalian RBCs demonstrates that AMP selectivity is more
complex than simple electrostatic interactions between cationic
peptide and anionic lipids [24,25].
The basis for the selectivity among mammalian species may
be a reflection of the difference in abundance of certain lipids.
Phosphatidylethanolamine (PE), for example, accounts for
33.3% of human erythrocyte membrane mass, but composes
47.3% and 67.8% of goat and sheep erythrocytes, respectively
[26]. Moreover, phosphatidylcholine (PC) is absent in goat and
sheep erythrocyte membranes, but makes up 30.3% of the lipid
composition in humans [26,27]. A better understanding of
membrane selectivity by these AMPs, such as cecropin
[28,29], magainin [30–32] and protegrin [33,34], is important
as it can contribute to the development of antibiotic, anti-tumor
and anti-infectious agents as well as targeted drug-delivery
agents [35]. In this work, we present results on the initial
interaction of PG-1 with model cell membranes with different
charge and packing characteristics.
PG-1 is an 18 amino acid, amidated peptide (NH2-
RGGRLCYCRRRFCVCVGR-CONH2) originally isolated
from porcine leukocytes [36]. Protegrins are part of the porcine
immune system, and functionally analogous to defensins in
humans [24] and circular (theta) defensins in the rhesus monkey
[37]. NMR studies have shown that PG-1 adopts a one-turn β
hairpin structure that includes two disulfide bonds [38,39]. This
peptide and some of its analogs have a wide range of known
targets, including Escherichia coli (gram-negative) [36], Neis-
seria gonorrhoeae (gram-negative) [40], Listeria monocyto-
genes (gram-positive) [36], Candida albicans (fungi) [41],
multidrug-resistant Mycobacterium tuberculosis [42] and pro-
tects against HIV infection in vitro [43].The apparent membrane disruptive ability of PG-1 was
observed with actual bacteria as well as model membrane
systems. Electron microscopy study has shown that PG-1 can
dramatically disrupt the outer membrane of Escherichia coli by
the formation of microvilli extending away from the membrane
surface [44] and the membrane of Neisseria gonorrhoeae by
forming cratered structures resembling an active “volcanic
terrain” [40]. Among model membrane systems, enhancement
of ion permeations in 3:1 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine:1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-
rac-(1-glycerol)] (POPC:POPG) liposomes (1μg/mL) and planar
lipid bilayers containing lipopolysaccharide or lipid A (4μg/mL)
have been shown to increase upon exposure to PG-1 [45].
A number of previous studies has been done to elucidate the
mechanism of the membrane disruption ability of PG-1. PG-1 has
been found to be stable in a lipid bilayer with a tilted orientation
(in multilamellar 1,2-dilauroyl-sn-glycero-3-phosphocholine sys-
tem) [46]. Apart from this favorable peptide–lipid interaction,
PG-1 can also oligomerize in the lipid environment [47,48].When
there is a mismatch in thickness between the lipid bilayer and the
peptide, the membrane deforms to minimize the hydrophobic
mismatch between the peptide and the surrounding lipid tail
groups when the peptide-to-lipid ratio reaches a certain threshold
value [46,49]. Beyond this threshold concentration, PG-1 and the
lipid head group change their relative orientation, suggesting the
alteration in the nature of the peptide–lipid interaction and
providing a possible signature for pore formation [50,51]. While
these studies elucidate the mechanism of membrane disruption,
relatively little work has focused on the molecular basis for PG-1
selectivity. In this paper, we present a systematic study on how
variousmembrane properties, such as head group size, head group
charge as well as tail group saturation and packing, affect the
membrane selectivity of PG-1.
A Langmuir monolayer held at a surface pressure where the
lipid packing density is equivalent to that of a lipid bilayer
serves as an excellent model for the outer leaflet of the cell
membrane [52]. Using a constant pressure insertion assay
whereby PG-1 was injected into the aqueous subphase below
the monolayer to model the initial interaction of the peptide with
the membrane surface, we quantified the amount of PG-1
insertion. The effect of PG-1 insertion on lipid packing was
achieved via concurrent monitoring with fluorescence micros-
copy (FM). In order to address the effect the lipid head group
has on PG-1 insertion, we have examined the interaction of PG-
1 with lipids that differ only in their head group structures. The
effect of tail group packing on PG-1 insertion has been assessed
by adjusting the surface pressure, by altering the degree of
saturation of the tail groups and by adding spacer molecules that
change the fluidity of the film.
2. Materials and methods
2.1. Materials
All phospholipids and ganglioside (GM1) were purchased from Avanti Polar
Lipids, Inc. (Alabaster, AL). Diphosphoryl lipid A from Escherichia coli F583 (Rd
mutant) and dihydrocholesterol (DChol) were purchased from Sigma-Aldrich (St.
Louis, MO). All lipids were used without further purification. Appropriate solvents
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0.2mg/ml: chloroform for 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC),
1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine (DPPE), 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-Phosphocholine (POPC), 1-Palmitoyl-2-Oleoyl-sn-Glycero-
3-Phosphoethanolamine (POPE), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-
rac-(1-glycerol)] (Sodium Salt) (POPG) and DChol; 9:1 chloroform:methanol for
1,2-Dipalmitoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] (Sodium Salt) (DPPG);
74:23:3 chloroform, methanol and water for lipid A. Solvents were obtained from
Fisher Scientific (HPLC grade, Pittsburgh, PA). Texas Red, 1,2-dihexadecanoylsn-
glycero-3-phosphoethanolamine (TR-DHPE), triethylammonium salt (Invitrogen
Co., Carlsbad, CA) was added to make up a solution with 0.5 mol% fluorescent
probe. The synthesis of PG-1 has been described elsewhere [39]. 1.0mg/mL PG-1
was prepared by dissolving in ultra-pure water (resistivity ≥18MΩcm, Milli-Q,
Millipore, Bedford,MA)with 0.01%glacial acetic acid (Fisher reagent grade acetic
acid) to prevent aggregation (theoretical pI=10.66) [53]. Dulbecco's phosphate-
buffered saline (D-PBS), without calcium and magnesium (pH=7.2, Invitrogen
Co., Carlsbad, CA), was used for the subphase for all the experiments.
2.2. Langmuir trough and Fluorescence Microscope (FM)
A home-built Langmuir surface balance was used for all surface pressure (Π)–
area (A) measurements. Details of this apparatus can be found in a previous
publication [54]. In brief, our apparatus consists of a Teflon trough with two
symmetric, movable barriers that allow for the control of the area of themonolayer.
AWilhelmy platemade of a filter paper, measures the change inΠ accompanied by
the change in area.Π is defined as γs–γm where γm and γs are surface tensions of
the monolayer and the subphase, respectively. Π (mN/m) and A (Å2/molecule)
were recorded at 1-s interval. The surface tension of the buffer subphase, γs, has
been approximated to that of the pure water. The temperature control was
maintained by a series of thermoelectric units (Omega Engineering Inc, Stamford
CT). A water circulator held at 20 °C (Neslab RTE-100; Portsmouth, NH) was
coupled to these units to provide a heat sink. A resistively heated indium tin oxide
coated glass plate (Delta Technologies, Dallas, TX) was placed over the entire
trough to minimize evaporation, dust contamination and condensation on the
microscope objective lens. The entire set-up is controlled by a custom software
interface designed using Lab View 6.0 (National Instruments, Dallas, TX).
In order to study the surface morphology of our systems concurrently with
Π–A isotherm measurements, we used a custom-built fluorescence microscope
(FM)with an extra-long working distance 50× objective (Nikon Y-FL, Fryer Co.,
Huntley, IL) positioned over the Langmuir surface balance. The entire balance
was mounted on x, y, and z translational stages for scanning and focusing. The
fluorescence emission of TR-DHPE (EX: 530–590nm; EM: 610–690nm)
premixed in the monolayer was selectively imaged using a filter cube (Nikon
HYQ Texas Red, Fryer Co., Huntley, IL). The real time morphological changes
were imaged by a charged couple device camera (Cohu Inc., Poway, CA), and
recorded on Super-VHS formatted or digital video tapes at video frame rate. FM
images were grabbed from video tapes as bitmap images (640×480 pixel) using
custom image grabbing software. These images were resized and enhanced in
brightness and in contrast for clear presentation.
2.3. Surface activity of PG-1
To determine the surface activity of PG-1, surface activity assays were
performed in the absence of any lipid at the bare air–buffer interface. Since no
lipid monolayer was present at the interface, the area between the two barriers
was kept constant during the experiment. The area equivalent to POPG at
30mN/m (66Å2/molecule), with the amount of lipid used for the experiments
described in the next section, was selected. Following the surface pressure
calibration, peptide solution was injected into the subphase using a syringe with
a L-shaped needle. PG-1 concentration ranging between 11.6nM to 11.6μMwas
used. Volume of the injected peptide solution was kept at 2mL. Immediately
after the injection, the surface pressure increased and continued to do so over
time. The maximum value was reached within 30min.
2.4. Constant pressure insertion assay
To quantify the interaction of PG-1 with monolayers, constant pressure
insertion studies were carried out. Fig. 1 shows the three steps involved in thisassay: monolayer compression, peptide injection and area expansion. Phospho-
lipid and lipid A solutions were spread drop-wise manually at the air–subphase
interface using a microsyringe (Hamilton, Reno, NV) to form a monolayer. The
total spread volume for each experiment was 50μL or 100μL given the
concentration of the spreading solutions 0.2mg/mL and 0.1mg/mL, respectively.
The solvents were allowed to evaporate for 15min under the atmosphere of
constantly streaming argon so that the vapors were purged out of the chamber.
For the case of lipid A, the time also allowed the small amount of water needed to
dissolve the lipid to be reincorporated into the subphase. Following this step, the
monolayer was compressed to a targetΠ. All the experiments were conducted at
pressures close to the bilayer equivalent surface pressure where the lipids are
packed at a density similar to that found in a biological membrane [55,56]. The
observed insertions therefore are directly relevant to in vivo/physiological
conditions. This range of surface pressure is higher than the equilibrium
spreading pressure of PG-1 (11.6μM), thus ensuring that observed area changes
are not merely due to the surface activity of the peptide. Upon reaching the target
pressure, the pressure was kept constant via a built-in feedback system that
adjusted the surface area by moving the barriers. The film was left to equilibrate
for 10min. In all experiments except for the concentration study with POPG
(where the peptide concentration ranged from 11.6nM to 11.6μM), stock PG-1
solution (1mg/mL) was injected into the subphase to make up the final PG-1
concentration of 11.6μM (0.025mg/mL). This particular concentration was
chosen as it is the 50% hemolytic concentration (HC50) for human RBCs. A
microsyringe with a L-shaped needle, VDRL needle (Hamilton, Reno, NV), was
used to homogeneously spread the mixture below the monolayer. The relative
change in area per molecule, ΔA/A, was monitored throughout the experiment.
Consequently, ΔA/A was used to compare the PG-1 insertion into different
monolayers. Subphase temperature was maintained at 30±0.5 °C for all
experiments. The cover glass temperature was adjusted to be 3 °C above the
subphase temperature to prevent condensation.
In order to prevent oxidation, extra precautions have been taken with
unsaturated lipid monolayers. The entire trough was sealed in a polyethylene bag
(AtmosBag, Sigma-Aldrich, St. Louis, MO) and purged with argon gas (grade 5.0)
by repeating three cycles of vacuum suction and argon purging. Everything required
for the experiment was placedwithin the bag before the purging, and all procedures
for the experiment were carried out using the two gloves attached to the bag.
3. Results
3.1. Surface activity of PG-1
The surface activity of PG-1 was first investigated at a
bare buffer surface. Fig. 2 shows the surface activity of PG-1
depends on peptide concentration (open square). Immediately
after injection, Π increased and continued to do so over time.
The maximum Π value was reached within 30min. Each
point represents the maximum Π increase after PG-1 injec-
tion. With increasing PG-1 concentration, Π increased non-
linearly. At 11.6μM of PG-1, the maximum Π increase was
10.3mN/m, whereas a mere 0.4mN/m increase was observed
for 116nM. Further decreasing the concentration to 11.6nM
still resulted in a similar surface pressure increase of 0.4mN/
m, which most likely represented the baseline increase upon
injection. The blank injection showed decrease of 0.2mN/m
due to the slight increase of subphase level.
3.2. Concentration dependence of PG-1 insertion into POPG
monolayers
Concentration dependence of PG-1 insertion into POPG
monolayers was studied at 30mN/m with PG-1 concentration
ranged from 11.6nM to 11.6μM. The volume of peptide solution
injected (2mL) was kept constant throughout the study. A new
Fig. 2. Surface activity of PG-1 for a bare air–buffer interface (□) and the
insertion of PG-1 into POPG monolayers at 30mN/m (•) are plotted against
PG-1 concentration. The data points at 0 and 11.6nM PG-1 directly overlap
one another. Temp=30 °C; Subphase=D-PBS.
Fig. 1. Constant Pressure Insertion Assay Steps. Shown above are three basic steps of the insertion assay. (1) Monolayer compression: the lipid monolayer at the air–
buffer interface is compressed to the target pressure which is comparable to the cell membrane environment. (2) Peptide injection: the peptide solution is slowly and
evenly injected below the monolayer using a gas-tight syringe equipped with an L-shaped needle. (3) Area expansion: as a result of peptide insertion, the surface
pressure increases. In order to keep the surface pressure constant, the area of the monolayer increases. The Langmuir trough is equipped with two movable barriers. The
surface morphology is observed using a fluorescence microscope during the experiment.
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point represents the maximum ΔA/A reached between 10 to
100min after the introduction of the peptide into the subphase.
The difference in the time it took to attain steady state was due
to the diffusion-limited nature of surface-active molecules
reaching the interface [57]. No insertion was observed with
blank and 11.6nM PG-1. A non-linear relationship between
PG-1 concentration and PG-1 insertion was observed as shown
in Fig. 2 (filled circle).
3.3. PG-1 insertion into monolayers
The capability of PG-1 to insert into DPPE, DPPC and
DPPG with fully saturated tails (16:0–16:0, two 16-carbon
chain tail groups with zero unsaturation) along with lipid A
monolayers was evaluated using the constant pressure insertion
assay at various surface pressures in order to understand the
head group selectivity of PG-1 along with the effect of lipid tail
Fig. 4. Maximum relative area change, ΔA/A (%), attained as a function of the
monolayer surface pressure for four different lipids: DPPE (▪), DPPC (○),
DPPG (▴) and lipid A (∇). Temp=30 °C; Subphase=D-PBS.
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insertion assay with a DPPC monolayer held constant at
20mN/m. Fig. 3A shows a typical Π–A isotherm plot. The
monolayer was spread at an area beyond the lift off area (95Å2/
molecule), compressed to the target pressure (20mN/m) and
equilibrated (indicated by arrow 0). PG-1 was injected into the
subphase (indicated by arrow 1) and as a result, the surface
pressure of the monolayer increased. To relieve the stress, the
area also increased over time (indicated by arrow 2) until it
reaches a steady state (indicated by arrow 3). Fig. 3B shows the
same experiment, but plotting ΔA/A over time.
Fig. 4 and Table 1 show the amount of PG-1 insertion into
various monolayers quantified by the relative area change,
ΔA/A, defined as (At−Ai) /Ai ×100%, where At is the area per
molecule at a given time after PG-1 injection into the subphase
and Ai is the area per molecule before PG-1 injection. Each
point represents the maximum relative area change, ΔA/A, after
the injection of PG-1 into the subphase. The observed kinetics
of insertions were non-linear and the maximum value reachedFig. 3. ATypical Constant Pressure Insertion Isotherm. DPPC/PG-1 at 20mN/m.
A typical isotherm from an insertion assay is shown in two different plots. (A)
Π–A isotherm: the monolayer was spread at an area beyond the lift off area
(95Å2/molecule), compressed to the target pressure (20mN/m) and equilibrated
(0). PG-1 was injected into the subphase (1) and as a result, the surface pressure
of the monolayer increased. To relieve the stress resulting from the inserted
peptide, the area increased over time (2 and 3). (B) ΔA/A change: the same
experiment can be plotted in respect to ΔA/A over time after injection (1).
Temp=30 °C; subphase=D-PBS.within 2 h of peptide injection, depending on the amount of
peptide insertion. No insertion was observed with all mono-
layers upon injection of blank buffer solution.
PG-1 insertion into lipid films clearly demonstrated a head
group preference. Among the different types of lipid head groups,
PG-1 inserted more favorably into anionic DPPG and lipid A
monolayers over zwitterionic lipid monolayers. A different
amount of PG-1 insertion was observed among zwitterionic
lipids. Between zwitterionic DPPC and DPPE monolayers, PG-1
inserted substantially more into DPPC, a lipid with a larger head
group. The insertion of PG-1 decreased linearly as a function of
increased surface pressure of the monolayer regardless of the type
of the monolayer. Higher surface pressure indicates tighter tail
group packing. For the case of lipid A, a deviation from the linear
decrease was observed at 35mN/m. At this pressure, PG-1
initially inserted into the lipid A monolayer reaching a maximum
area change of 15%. Shortly after the peak, ΔA/A plummeted to
the negative territory over the course of an hour [44].
3.4. Tail group packing studies
While the most abundant lipid tail groups in animal and plant
membranes are saturated chains with 14, 16 and 18 carbon atoms
[58], unsaturated tail groups are also common components of
cell membranes. The effect of substituting one or two of the
saturated lipid tail group(s) with amonounsaturated tail group onTable 1
PG-1 induced relative area change of lipid monolayers
Π (mN/m) PG-1 Insertion (ΔA/Amax)
DPPE (+/−) DPPC (+/−) DPPG (−) lipid A (−)
20 11 59 121 117
25 12 22 57 60
30 0 0 17 21
35 0 0 0 15
Maximum relative area change, ΔA/A (%), of various lipid monolayers held at
different constant surface pressures after injection of PG-1. The charge of the
head group is indicated in the bracket. [PG-1]=25μg/mL (11.6μM);
Temp=30 °C; Subphase=D-PBS.
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insertion assay (Table 2). Comparisons were made between
DPPE (16:0–16:0) and POPE (16:0–18:1), DPPC (16:0–16:0)
and POPC (16:0–18:1), DPPC (16:0–16:0) and DOPC (18:1–
18:1), and DPPG (16:0–16:0) and POPG (16:0–18:1). Cartoon
representations of unsaturated and saturated lipid molecules are
shown at the top and the bottom of the figure, respectively, the
ratio of ΔA/A between unsaturated and saturated lipids are
shown in the middle, and surface pressures at which the mono-
layer was held constant are shown below the insertion ratio.
An overall enhancement of PG-1 insertion was observed in
all groups as a result of substituting one saturated tail with an
unsaturated tail. The sequential substitution of unsaturated tail
group to DPPC resulted in the progressive enhancement of PG-1
insertion in POPC (1.8) and DOPC (2.4). Comparison between
DPPG and POPG was carried out at a higher surface pressure
because PG-1 inserted into DPPG monolayer even at 30mN/m,
and the effect of unsaturated lipid tail group on PG-1 insertion
was found to be further enhanced at 30mN/m (2.1) compared to
that at 25mN/m (1.3).
The tail group packing density can also be altered by the
addition of DChol or GM1 to themonolayer. PG-1 insertion assay
was tested with 7:3 POPC:DCholmonolayer at 30mN/m and 8:2
DPPC:GM1 at 25mN/m. A different trend was observed betweenTable 2
Enhancement of peptide insertion in the presence of unsaturated tail groups
PG-1 insertion into fully saturated (S) lipid monolayers of DPPC, DPPE and
DPPG were compared with insertion in lipids with one or two tail groups
substituted with unsaturated (U) tail group(s) (POPE, POPC, DOPC, POPG).
The effects of tail group substitution are shown by taking the ratio of insertion
into the unsaturated lipid monolayer, (ΔA/A)
U
, to insertion into the saturated
lipid monolayer, (ΔA/A)
S
. A number greater than 1 reflects an enhancement of
peptide insertion in the unsaturated system. Temp=30 °C; Subphase=D-PBS.these two systems. The ratio of the relative area change between
7:3 POPC:DChol and POPC at 30mN/mwas 0.2, demonstrating
a significant decrease in the PG-1 insertion when DChol was
present. Contrary to the effect of DChol, the relative area change
between 8:2 DPPC:GM1 and DPPC at 25mN/m was 1.4,
signifying an increase in PG-1 insertion with GM1 in the film.
3.5. Membrane disordering by PG-1
The effect of PG-1 insertion on the morphology of the lipid
monolayer was observed using fluorescence microscopy. This
technique is applicable when condensed phase is present in the
monolayer at the desired surface pressure. Under our experimental
conditions, wewere able tomonitormorphological changes for all
saturated phospholipid monolayers (DPPE, DPPC and DPPG).
Fig. 5 shows FM images of the monolayer before and after the
injection of PG-1 into the subphase. Post injection images were
captured after ΔA/Awas reached for each film.
Fluorescent dye tagged lipid, Texas Red-DHPE, favorably
partitioned into the less packed liquid phase of the monolayer,
leaving the condensed phase dark. In general, the area fraction
of the dark condensed phase decreased as PG-1 inserted into the
monolayer. This indicates the disordering of lipid packing in the
monolayer. Most of the disordering effects took place in the first
10min, starting at the liquid-condensed phase boundaries. For
DPPE, the presence of PG-1 does not result in any significant
morphological changes in the film at 25 and 30 mN/m (Fig.
5A–D), indicating little peptide insertion. In contrast, PG-1
alters the morphology and reduces the area fraction of the
condensed phase for DPPC (from Fig. 5E–F) and more so for
DPPG (Fig. 5I–M), with changes being more drastic at the
lower surface pressure. Although no measurable amount of
ΔA/Awas recorded, indicating that there is no peptide insertion
into the tail portion of the film, an increase in the amount of the
brighter phase was observed with DPPC at 30mN/m. This result
indicates that the association of the peptide to the lipid film can
give rise to a change in the film's surface in spite of the lack of
any detectable peptide insertion by the insertion assay. Fig. 6
shows DPPG monolayer at 25mN/m 3min after the injection of
PG-1 into the subphase. The progressive blurring of the domains
from Fig. 6A–D clearly shows the disordering process at the
condensed domain edges. Each image is not at the identical
location due to the lateral drift of the monolayer. While extra
precaution was taken to homogeneously spread PG-1 solution,
different degrees of disordering were observed at different parts
of the monolayer, indicating the existence of a certain degree of
heterogeneity in PG-1 injection. However, the trends of the
surface morphological changes depicted in Figs. 5 and 6 are
highly reproducible from experiment to experiment.
4. Discussion
4.1. Concentration-dependent PG-1 activity
There are a number of proposed AMP-induced membrane
disordering mechanisms, of which the barrel stave [3–6], the
carpet [7–9] and the torroidal model [10–12], are the most
Fig. 5. FM images of DPPE (A–D), DPPC (E–H) and DPPG (I–M) phase morphology before and after the injection of PG-1 beneath the monolayer (between 30–
60min). The surface pressures are 25 and 30mN/m. Temp=30 °C; Subphase=D-PBS.
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over hundreds of peptide sequences that are classified as AMPs.
However, one common requirement to all AMPs' mechanism in
membrane disordering is that the peptide initially adsorbs onto the
cell membrane from the extracellular media. It is likely that once
the AMPs accumulate on the surface beyond a certain
concentration threshold, theymay cooperatively insert themselves
into the membrane to inducemembrane disordering. Recently, we
have also directly observed the disruptive effects of PG-1 in
supported lipid bilayers using atomic force microscopy [59].
As shown in Fig. 2, the activity of PG-1 with POPG
monolayer is highly concentration-dependent. The insertion of
PG-1 into a POPG monolayer at 30mN/m was observed at all
concentrations beyond the lowest concentration (11.6nM).
While the surface activity of PG-1 and the insertion of PG-1
into a POPG monolayer show a correlation to each other, a
much sharper increase in PG-1 insertion was observed at lower
PG-1 concentration range. In particular, the surface pressure
increase with 116nM PG-1 was merely 0.4mN/m with a bare
air–buffer interface, yet a significant amount of insertion (16%)
was observed in the presence of POPG monolayer for the sameFig. 6. PG-1 induced packing disordering initiates at the liquid-condensed phase
boundary. FM images of DPPG monolayer were captured 3min after the
injection of PG-1 into the subphase. The progressive blurring of the domains
from A–D clearly shows the disordering process at the condensed domain
edges. Scale bar=50μm; Π=25mN/m; Temp=30 °C; Subphase=D-PBS.peptide concentration. The concentration dependence of AMPs
has been reported to be sigmoidal with alamethicin and δ-lysin
[23,60], exhibiting a sharp transition from a surface associated
state to an inserted state at certain threshold concentrations. Our
results indicate a similar sharp transition for PG-1 in its ability
to insert into the POPG film. While no insertion was observed at
11.6nM, PG-1 inserts readily into the lipid film at a subphase
concentration of 116nM. The sharp concentration dependence
of PG-1 activity is an important characteristic for the peptide to
possess in order to function as an effective antimicrobial agent.
In multilamellar lipid system where the peptide and the lipid are
premixed, PG-1 exhibits a sharp transition in its orientation with
respect to the lipid [50], and is capable of inducing a sudden
change in the head group conformation beyond a certain lipid to
peptide ratio [46].
In order to evaluate the differences in PG-1 ability to insert
into various monolayers, it is important to ensure that the
constant pressure assays are conducted at pressures higher than
the pressure attainable by the peptide in the absence of any lipid
film. This allows us to distinguish between the surface activity
of peptide from lipid/peptide interaction. Indeed, our surface
activity study of the peptide at the bare air–buffer interface
shows that the maximum surface pressure attained with 11.6μM
of PG-1 in the subphase was 10.3mN/m, a pressure much lower
than the ones used for our insertion assays.
4.2. Head group selectivity
The head group of the membrane lipid is the first portion of
the membrane encountered by PG-1. Consequently, the
chemical properties of the head group, specifically the
electrostatic property and the size of the head group, play an
important role in the membrane selectivity of PG-1.
The highest degree of PG-1 insertion was observed in lipids
with anionic head groups, DPPG and lipid A. The origin of this
preferential interaction comes from the electrostatic attraction
between the cationic PG-1 (+7) and these anionic lipids. Lipid
A is the lipid anchor of lipopolysaccharide that is found at the
outer membrane of Gram-negative bacteria, and lipids with the
PG head group are predominant in the plasma membrane of
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hand, only zwitterionic lipids are found in the outer leaflet of the
mammalian RBC membrane. Due to favorable electrostatic
interactions, the presence of anionic lipids increases the local
concentration of PG-1 at the monolayer surface. Consequently,
a higher degree of insertion is observed with anionic compared
to zwitterionic lipid films. An additional contribution of the
anionic head group to PG-1 insertion comes from the charge–
charge repulsion between neighboring head groups. The
repulsion between anionic head groups increases the effective
head group size making them more accessible for the insertion
of PG-1’s.
The differences obtained in the PG-1 insertion among
zwitterionic lipids (PC vs. PE) show that electrostatics of the
head group alone cannot explain the observed selectivity.
Comparing lipids with saturated tails and their unsaturated
counterparts, we find that PG-1 inserts more favorably into
monolayers with PC head groups over PE head groups. One
explanation for this preference for PC is the head-tail mismatch
of the lipid. The cross sectional diameter of the PC head group is
larger than that of the two saturated tail groups, whereas that of
PE is smaller. With DPPC, the large head group prevents lipid
tails to pack as tightly as those in DPPE held at identical surface
pressure and subphase conditions [61]. As demonstrated from
X-ray reflectivity results, the tail groups of DPPC tilt even at
relatively high surface pressures, resulting in a rectangular unit
cell [52]. On the other hand, DPPE molecules are able to pack
tightly with the tails arranged in a hexagonal unit cell at
comparable pressure [62]. Tightly packed tail groups of DPPE
thus prevent PG-1 to effectively insert into the monolayer.
While the membranes of mammalian RBCs are constituted by
similar lipid species, the ratio of these species differ among pigs,
sheep and human. Sheep RBC contains a higher amount of PE
lipids and a lower amount of PC lipids compared to human
RBC. Both factors contribute towards protecting the cell from
peptide insertion. This difference in the lipid composition of the
cell membrane may explain the difference in PG-1 susceptibility
among mammalian species.
4.3. PG-1 insertion into various tail group packing
The insertion results obtained using monolayers with various
tail group packing clearly point to the effects of tail group
packing density on peptide insertion. Similar to the head group
size effect discussed above, an increase in tail group packing
tends to decrease PG-1 insertion. This effect is apparent when
the packing density of the lipid tail groups is increased by
increasing the surface pressure of the monolayer (Fig. 4). The
decrease in PG-1 insertion appears to be linear for all lipids
examined except for the lipid A monolayer at high surface
pressure. At 35mN/m, a quick initial increase in the area of the
lipid A monolayer indicates the insertion of PG-1. However,
instead of maintaining the increased area, the film decreases in
its area, indicating a possible loss of material into the subphase.
The area decrease may also take place as a result of rearrange-
ment of lipid molecules in the monolayer held at a constant
surface pressure, but the rate of area decrease post PG-1insertion is significantly faster than the area decrease observed
for molecular rearrangement. The insertion of PG-1 into the
lipid A monolayer possibly increases the solubility of the lipid
A molecules, leading to the destabilization of the lipid film by
the process of micellization. This is plausible since the solubility
of lipid A in aqueous phase is higher than other phospholipids
indicated by the requirement of a more hydrophilic solvent for its
dissolution (see Materials). This solubilized structure is perhaps
similar to the vesicle/micelle phase recently observed through
NMR with POPC:POPG system, but not with pure POPC
system, after addition of PG-1 [63]. A possible micellization
process has also been observed with using a linear AMPs
pardaxin and magainin [64,65].
There are a number of ways in which the cell membrane
regulates the packing density of its membrane components, and
unsaturation of the tail group is one of them. Comparison of the
degree of PG-1 insertion between DPPC, POPC and DOPC
clearly shows an increase in PG-1 insertion as more unsaturated
tail groups are present in the film. The double bond gives rise to
a kink in the unsaturated lipid tail group, preventing the close
packing of the tails. Unlike DPPC, Π–A plots for both POPC
and DOPC monolayers do not exhibit a liquid to condensed
phase transition under our experimental conditions (data not
shown). The looser packing created by the unsaturated tail
group thus allows PG-1 to insert into the monolayer more easily.
While PG-1 insertion is enhanced by lipid tail unsaturation,
the opposite effect is observed when the cholesterol is present in
the lipid film. Cholesterol is an integral component in the
mammalian cell membrane. Structurally it is a rather flat
molecule. Its sterol rings can fit nicely in the lipid tail region and
its hydroxyl group helps to anchor it at the lipid head–tail
interface. In effect, cholesterol can be thought of as an
intercalator in the lipid film, functioning as a spacer to
compensate the head–tail size mismatch and increase the
packing density of the tail region. It is therefore not surprising
that PG-1 inserts less into a POPC/DChol compared with a
POPC monolayer. From the binding energy study of cationic
peptide LamB-W (a cationic analog of the LamB signal
peptide), addition of 40% cholesterol to egg-PC vesicle system
resulted in a decrease in the binding energy by 1.5 kcal/mol
[66].
Addition of 20% GM1 to DPPC, on the other hand, has led to
an increase in PG-1 insertion. The observed increase is likely due
to the competition between two opposing effects brought about
by the addition of GM1: lipid packing and surface charge. GM1 is
a glycolipid commonly present in the mammalian cell
membrane as a signaling molecule, and it has a large penta-
saccharide attached to two acyl tail groups. The large sugar
groups may be thought of as hindering lipid packing due to steric
hindrance, but the addition of 20%GM1 to a DPPCmonolayer in
fact acts to allow the lipids to pack more tightly and lowers the
phase transition surface pressure (data not shown). This means
that the 8:2 DPPC:GM1 monolayer has a higher content of the
condensed phase than the pure DPPC monolayer. This
condensing effect of GM1 has been observed in the Π–A plot
of the monolayer as well as the earlier appearance of the
condensed phase in FM images. The lack of a phosphate group
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between the large head group of DPPC molecules and enhance
the lipid packing. As discussed earlier, this increase in packing
density would decrease PG-1 insertion. On the other hand, the
sialic acid on one of the sugar groups in GM1 adds a negative
charge to the surface. As we discussed earlier, this acts to
increase the local concentration of PG-1 near the monolayer, and
hence the insertion of PG-1. Despite of the increased packing
effect of GM1, the enhanced observed insertion shows that local
accumulation of peptides along the surface brought about by the
GM1 plays a stronger role in PG-1 activity.
4.4. PG-1 lipid packing disordering
The fact that the membrane insertion of PG-1 disorders the
lipid tail group packing is clearly demonstrated by the decrease
in the area fraction of the dark condensed phase for DPPE,
DPPC and DPPG at 25mN/m (Fig. 5B, F, K) and DPPG at
30mN/m (Fig. 5M) after the injection of PG-1. No morpho-
logical change was seen upon PG-1 injection in DPPE
monolayer at 30mN/m due to the closely packed tail groups
(Fig. 5D). Although no detectable ΔA/A was measured with
DPPC at 30mN/m, a small morphological change was observed
(Fig. 5H). This demonstrates that PG-1 is surface-associated,
but cannot penetrate into the monolayer at this surface pressure.
The disordering process is initiated at the liquid-condensed
phase boundary. As seen in the blurring of the condensed phase
domains in Fig. 6, the peptide first inserts into the liquid phase
and then destabilizes the condensed phase, using the boundary as
a weak point for insertion. One of the driving forces for PG-1
insertion is the hydrophobic matching between the peptide and
the lipid tail group. X-ray reflectivity data have previously
shown that when PG-1 inserts, it spans through both the head
group and tail group regions of the lipid monolayer [44]. The
condensed domains observed in FM images originate from the
nucleation of closely packed tail groups of lipid molecules.
Deeply penetrated PG-1 acts to melt these domains by
associating with the surrounding tail groups. Strong tail
group–peptide interaction has been suggested by the membrane
thinning effect observed with multilamellar lipid systems [49].
The findings of this work suggest that when the thickness of the
lipid bilayer (∼4nm) is thicker than the length of the peptide
(3nmwhen fully extended), the acyl chains deforms tomatch the
hydrophobic regions of the inserted peptide. The length scale of
such thickness deformation ranges from several angstroms [49]
to nanometer scale [67]. In our insertion assay, the area of the
monolayer expands in order to compensate for the increased
surface pressure due to PG-1 insertion. The area increase is due
to the presence of the peptide in the lipid film, which leads to an
effective increase in the area-per-molecule occupied by the
lipids. Furthermore, peptide insertion disorders the lipid film,
resulting in a similar deformation of the tail group.
5. Conclusion
Our results delineate several important membrane properties
that affect the initial membrane selectivity of PG-1. The abilityof PG-1 to initially associate with and insert into a lipid film
exhibits a sharp dependence on peptide concentration. Given
the same overall peptide concentration, the local concentration
of PG-1 at the membrane surface is greatly enhanced by the
presence of anionic lipid molecules that are prevalent in the
bacterial membrane. Highest degree of PG-1 insertion has been
observed with anionic lipid monolayers, while zwitterionic
lipids only show a moderate amount of insertion at low surface
pressure. The packing density of the lipid plays an important
role in PG-1 insertion. Systematically altering the way the lipid
molecules pack by changing the surface pressure, substituting
saturated with unsaturated tail groups, and adding DChol and
GM1 to the film, shows that the packing density is inversely
proportional to the amount of PG-1 insertion. Our PG-1
insertion study using the Langmuir monolayer thus provides a
clear demonstration of the effect of individual chemical and
physical properties on the membrane selectivity of PG-1.
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